Nicholas Brousseau

1.3k total citations
48 papers, 461 citations indexed

About

Nicholas Brousseau is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Nicholas Brousseau has authored 48 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 14 papers in Infectious Diseases and 13 papers in Health. Recurrent topics in Nicholas Brousseau's work include Respiratory viral infections research (16 papers), Pneumonia and Respiratory Infections (13 papers) and Vaccine Coverage and Hesitancy (13 papers). Nicholas Brousseau is often cited by papers focused on Respiratory viral infections research (16 papers), Pneumonia and Respiratory Infections (13 papers) and Vaccine Coverage and Hesitancy (13 papers). Nicholas Brousseau collaborates with scholars based in Canada, Ivory Coast and United Kingdom. Nicholas Brousseau's co-authors include Gaston De Serres, Danuta M. Skowronski, Moussa Ouakki, Geneviève Deceuninck, Philippe De Wals, Rodica Gilca, Nicole Boulianne, Chantal Sauvageau, Brian J. Ward and Denis Talbot and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Nicholas Brousseau

40 papers receiving 452 citations

Peers

Nicholas Brousseau

EPIDE

HEALT

Marino Faccini Italy

Ann Moen United States

Jill Watson Australia

Kwok‐Hung Chan Hong Kong

Hester Allen United Kingdom

Olubukola T. Idoko Gambia

Janessa Pickering Australia

Sue Reynolds United States

Anja Saso United Kingdom

Marino Faccini Italy

Nicholas Brousseau

327 ×1.4

EPIDE

166 ×0.9

113 ×0.6

HEALT

21 ×0.4

27 ×0.5

Citations per year, relative to Nicholas Brousseau Nicholas Brousseau (= 1×) peers Marino Faccini

Countries citing papers authored by Nicholas Brousseau

Since Specialization

Citations

This map shows the geographic impact of Nicholas Brousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Brousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Brousseau more than expected).

Fields of papers citing papers by Nicholas Brousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Brousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Brousseau. The network helps show where Nicholas Brousseau may publish in the future.

Co-authorship network of co-authors of Nicholas Brousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Brousseau. A scholar is included among the top collaborators of Nicholas Brousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Brousseau. Nicholas Brousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Killikelly, April, et al.. (2025). Summary of the National Advisory Committee on Immunization (NACI) statement on the prevention of respiratory syncytial virus (RSV) in older adults. Canada Communicable Disease Report. 51(8). 292–296.

Carazo, Sara, Danuta M. Skowronski, Katia Giguère, et al.. (2025). Effectiveness of COVID-19 Vaccination and Prior Infections to Reduce Long COVID Risk During the Pre-Omicron and Omicron Periods. Clinical Infectious Diseases. 82(3). e436–e445.

Killikelly, April, et al.. (2025). Summary of the National Advisory Committee on Immunization (NACI) Statement on the Prevention of Respiratory Syncytial Virus (RSV) in Infants. Canada Communicable Disease Report. 51(4). 113–118. 1 indexed citations

Carazo, Sara, Danuta M. Skowronski, Nicholas Brousseau, et al.. (2025). Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: Impact of variant replacement and waning protection during 10-month follow-up. PLoS ONE. 20(6). e0325269–e0325269. 2 indexed citations

Abrams, Elissa M., et al.. (2025). Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infection. Canada Communicable Disease Report. 51(1). 26–34. 4 indexed citations

Brousseau, Nicholas, et al.. (2024). Vaccination during pregnancy and modulation of IgG response to pertussis vaccines in infants: The impact of different vaccine formulations. Vaccine. 42(9). 2138–2143. 2 indexed citations

Deceuninck, Geneviève, et al.. (2024). Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study. Human Vaccines & Immunotherapeutics. 20(1). 2305522–2305522.

Tuite, Ashleigh R., Gebremedhin Beedemariam Gebretekle, April Killikelly, et al.. (2024). Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost–utility analysis. Canadian Medical Association Journal. 196(29). E989–E1005. 4 indexed citations

Sadarangani, Manish, Marina Ulanova, Scott A. Halperin, et al.. (2023). Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules?. Vaccine. 41(45). 6745–6753.

10.

Brousseau, Nicholas, Sara Carazo, Geneviève Cadieux, et al.. (2023). Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk. Clinical Infectious Diseases. 78(2). 461–469. 14 indexed citations

11.

Lo, Ernest, et al.. (2023). Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Quebec, Canada, during the Delta and early Omicron periods. Vaccine. 42(3). 636–644.

12.

Golden, Alyssa, Brigitte Lefebvre, Geneviève Deceuninck, et al.. (2023). Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016–2021. Vaccine. 41(44). 6612–6618. 1 indexed citations

13.

Carazo, Sara, Danuta M. Skowronski, Marc Brisson, et al.. (2022). Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. The Lancet Infectious Diseases. 23(1). 45–55. 55 indexed citations

14.

Carazo, Sara, Denis Talbot, Nicole Boulianne, et al.. (2021). Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada. Clinical Infectious Diseases. 75(1). e805–e813. 22 indexed citations

15.

Brousseau, Nicholas, Danuta M. Skowronski, David Bellemare, et al.. (2019). Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada. Vaccine. 38(3). 427–432. 4 indexed citations

16.

Desjardins, Michaël, et al.. (2018). Clinical characteristics of pediatric pertussis cases, Quebec 2015–2017. Canada Communicable Disease Report. 44(9). 190–195. 10 indexed citations

17.

Brousseau, Nicholas, et al.. (2016). Illness absenteeism rates in primary and secondary schools in 2013–2014 in England: was there any impact of vaccinating children of primary-school age against influenza?. Epidemiology and Infection. 144(16). 3412–3421. 2 indexed citations

18.

Brousseau, Nicholas, Nick Andrews, Pauline Waight, et al.. (2015). Antibody Concentrations Against the Infecting Serotype in Vaccinated and Unvaccinated Children With Invasive Pneumococcal Disease in the United Kingdom, 2006–2013. Clinical Infectious Diseases. 60(12). 1793–1801. 5 indexed citations

19.

Serres, Gaston De, Nicole Boulianne, Fannie Defay, et al.. (2012). Higher Risk of Measles When the First Dose of a 2-Dose Schedule of Measles Vaccine Is Given at 12–14 Months Versus 15 Months of Age. Clinical Infectious Diseases. 55(3). 394–402. 69 indexed citations

20.

Lévesque, Benoît, et al.. (2010). Assessment of real-time PCR for quantification of Legionella spp. in spa water. Letters in Applied Microbiology. 51(6). 639–644. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact